Skip to main content

Artistes, producers, record labels flock MCSN’s Gocreate App

The Gocreate App, which was recently launched by Musical Copyright Society of Nigeria (MCSN), has ushered a great awakening for the Nigerian music industry.

Gocreate App equips right owners with data from airplay reports and analytics, and this makes rights management and royalty distribution more transparent and effective.

ALSO READ: Effium killings: Declare state of emergency in Ebonyi to save lives, AESID urges FG

According to MCSN’s Managing Director, Mayo Ayilaran, within three weeks of the deployment of Gocreate App, the Collective Management Organization (CMO) has recorded 30% increase in its membership base. With this feat, stakeholders agreed that MCSN has taken a golden step in the right direction by making the technology available to right owners in Nigeria, especially to artistes, producers, writers and record labels, who are downloading the app in droves.

“The Nigerian music industry is very vibrant and it’s no surprise that stakeholders have embraced this cutting edge innovation that allows right owners to register with MCSN by downloading the Gocreate App through the App store or Google play store, and upload their catalogues for tracking and monitoring. The technology has also made royalty payment process transparent and easier,” he stated.

Ayilaran disclosed further that the Gocreate technology currently monitors over 1,000 radio and TV stations across Nigeria and Africa. “This innovative technology does not exist anywhere else in the world. So, the Nigerian music industry would soon become the envy of all creative industries across the globe,” he boasts.

Vanguard News Nigeria 

The post Artistes, producers, record labels flock MCSN’s Gocreate App appeared first on Vanguard News.


by Temisan Amoye via Vanguard News https://ift.tt/3sEzAG8 Best Known Member of the Cabinet Wikipedia

Comments

Popular posts from this blog

Effective Data Governance: IIM-Africa inks partnership deal with Data Management University

President/Chairman of the governing council of IIM-Africa, Dr. Oyedokun Oyewole has said that effective data governance strategy has become more essential for the survival and sustenance of government and businesses, especially with the sudden outbreak of COVID-19 Pandemic. Oyewole said there is the need to ensure that the right policies, processes, technology, and people are in place to effectively manage data while complying with legal and regulatory requirements. He said that as part of the IIM Africa’s commitments towards ensuring global best practices, it has entered into a long-term partnership with DataManagementU.com to bring the finest data management training to industries across Africa. READ ALSO:  COVID-19: Foreign affairs minister says first set of Nigerians abroad to be evacuated soon According to the IIM President, the alliance is expected to provide members of the Institute and other professionals across Africa, high standards, internationally-recognized learn...

Naomi Osaka’s statement about withdrawing from French Open

Japan’s Naomi Osaka returns the ball to Romania’s Patricia Maria Tig during their first round match of the French open tennis tournament at the Roland Garros stadium Sunday, May 30, 2021 in Paris. (AP Photo/Christophe Ena) Naomi Osaka tweeted the following statement announcing her withdrawal from the French Open on Monday: “Hey everyone, this isn’t a situation I ever imagined or intended when I posted a few days ago. I think now the best thing for the tournament, the other players and my well-being is that I withdraw so that everyone can get back to focusing on the tennis going on in Paris. ”I never wanted to be a distraction and I accept that my timing was not idea and my message could have been clearer. ”More importantly I would never trivialize mental health or use the term lightly. The truth is that I have suffered long bouts of depression since the US Open in 2018 and I have had a really hard time coping with that. Anyone that knows me knows I’m introverted, and anyone tha...

Remdesivir: The COVID-19 drug helping patients recover faster

A vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. PHOTO: AP Remdesivir has been shown to speed up recovery times for patients with COVID-19 in a major US-led trial, becoming the first drug with proven benefit against the disease. Here is what you need to know. – What is remdesivir? – Remdesivir is an experimental, broad spectrum antiviral made by US pharmaceutical Gilead Sciences that was first developed to treat Ebola, a viral hemorrhagic fever. It showed early promise in a primate study in 2016 and was later rolled out for a major trial in the Democratic Republic of Congo, where it was compared against three other medicines. That study concluded in 2019 when it was discontinued because it did not boost survival rates as greatly as two monoclonal antibody drugs, which are lab-engineered immune system proteins. In February, the US National Institute of Allergy and Infectious Diseases (NIAID) announced ...